ABT · Healthcare
Abbott Laboratories
34/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
46
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$195.1B
Industry
Medical Devices
Sector
Healthcare
Exchange
NYSE
About ABBOTT LABORATORIES
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and…
Who's behind the signal
Every informed buyer we can see on ABT, across all three feeds.
Hedge funds · 8
Soros Fund Management (Soros)
New position
D.E. Shaw & Co
Increased +290%
Tudor Investment (Paul Tudor Jones)
Increased +92%
Millennium Management (Englander)
Increased +208%
Gotham Asset Mgmt (Greenblatt)
Increased +113%
AQR Capital Management
Increased +46%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 46 on record
Disclosures from 2015-02-12 to 2022-09-21
The newest disclosure we hold for this stock is 2022-09-21.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-09-21 | David B. McKinley · R-WV | House | Sold | $1,001 - $15,000 |
| 2022-07-15 | Robert J. Wittman · R-VA | House | Bought | $1,001 - $15,000 |
| 2022-06-16 | Robert J. Wittman · R-VA | House | Sold | $1,001 - $15,000 |
| 2022-04-19 | Robert J. Wittman · R-VA | House | Bought | $1,001 - $15,000 |
| 2022-03-15 | Robert J. Wittman · R-VA | House | Sold | $1,001 - $15,000 |
| 2022-01-07 | Michael C. Burgess · R-TX | House | Sold | $1,001 - $15,000 |
| 2021-12-02 | Michael C. Burgess · R-TX | House | Bought | $1,001 - $15,000 |
| 2021-10-28 | Kim Schrier · D-WA | House | Sold | $1,001 - $15,000 |
| 2021-06-15 | Ro Khanna · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-06-14 | Ro Khanna · D-CA | House | Bought | $1,001 - $15,000 |
Show the other 36
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-03-04 | Carol D. Miller · R-WV | House | Bought | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer · R-MI | House | Sold | $15,001 - $50,000 |
| 2021-02-11 | Ro Khanna · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-02-11 | Ro Khanna · D-CA | House | Bought | $15,001 - $50,000 |
| 2021-01-05 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-11-10 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2020-11-05 | Katherine M. Clark · D-MA | House | Sold | $1,001 - $15,000 |
| 2020-10-22 | Katherine M. Clark · D-MA | House | Bought | $1,001 - $15,000 |
| 2020-09-28 | K. Michael Conaway · R-TX | House | Bought | $50,001 - $100,000 |
| 2020-09-28 | K. Michael Conaway · R-TX | House | Bought | $15,001 - $50,000 |
| 2020-09-23 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-08-28 | David B. McKinley · R-WV | House | Sold | $1,001 - $15,000 |
| 2020-08-07 | Joe Courtney · D-CT | House | Sold | $1,001 - $15,000 |
| 2020-07-28 | Carol D. Miller · R-WV | House | Bought | $15,001 - $50,000 |
| 2020-04-30 | David B. McKinley · R-WV | House | Bought | $1,001 - $15,000 |
| 2020-04-07 | Kelly Loeffler · R-GA | Senate | Bought | $1,001 - $15,000 |
| 2020-04-02 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-03-27 | John R. Curtis · R-UT | House | Bought | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-03-13 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-03-03 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2020-02-28 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
| 2019-12-31 | Joe Courtney · D-CT | House | Bought | $1,001 - $15,000 |
| 2019-04-09 | Tina Smith · D-MN | Senate | Sold | $250,001 - $500,000 |
| 2018-04-24 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2018-04-05 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2017-10-24 | Bill Cassidy · R-LA | Senate | Sold | $1,001 - $15,000 |
| 2017-10-18 | Tammy Duckworth · D-IL | Senate | Sold | $1,001 - $15,000 |
| 2017-02-23 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2016-11-15 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2016-04-19 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2016-03-31 | Bill Cassidy · R-LA | Senate | Bought | $1,001 - $15,000 |
| 2015-07-21 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2015-07-09 | James M. Inhofe · R-OK | Senate | Sold | $50,001 - $100,000 |
| 2015-02-12 | Thomas R. Carper · D-DE | Senate | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
ABBOTT LABORATORIES isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
1
New positions
5
Increasing
2
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.5×
% of portfolio
0.1%
Position change
NEW
0.1% of Soros Fund Management's portfolio
Trust weight: 1.0×
% of portfolio
0.5%
Position change
+290%
0.5% of D.E. Shaw & Co's portfolio
Trust weight: 1.2×
% of portfolio
0.2%
Position change
+92%
0.2% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+208%
0.1% of Millennium Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+113%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+46%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−8%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
−5%
0.1% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ABBOTT LABORATORIES
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ABBOTT LABORATORIES or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime